The effect of KIR ligand incompatibility on the outcome of unrelated donor transplantation: a report from the center for international blood and marrow transplant research, the European blood and marrow transplant registry, and the Dutch registry.

Keywords

Computer science, Philosophy

References

• Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome.Salvador Aldana Fernández — 2004
• Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation.Loredana Ruggeri, Marusca Capanni, Myriam Casucci — 1999
• 1994 Consensus Conference on Acute GVHD Grading.Donna Przepiorka, Daniel Weisdorf, Peyton Martin — 1995
• Determinants of Antileukemia Effects of Allogeneic NK Cells 1Wing Leung, Rekha Iyengar, Victoria Turner — 2004
• Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients.Howard M. Shulman, Keith M. Sullivan, Paul L. Weiden — 1980
• Results of allogeneic bone marrow transplants for leukemia using donors other than HLA-identical siblings.Richard Szydlo, John M. Goldman, John P. Klein — 1997
• The beneficial role of inhibitory KIR genes of HLA class I NK epitopes in haploidentically mismatched stem cell allografts may be masked by residual donor-alloreactive T cells causing GVHD.Amal Bishara, Dianne De Santis, Campbell Witt — 2004
• Estimation of failure probabilities in the presence of competing risks: new representations of old estimators.Ted Gooley, Wendy M. Leisenring, John Crowley — 1999
• Proposals for the classification of the myelodysplastic syndromesJohn M. Bennett, Daniel Catovsky, M. T. Daniel — 1982
• Alloreactive killer cells: hindrance and help for haematopoietic transplantsPeter Parham, Karina L. McQueen — 2003
• Evaluation of KIR ligand incompatibility in mismatched unrelated donor hematopoietic transplants. Killer immunoglobulin-like receptor.Stella M. Davies, Loredana Ruggieri, Todd E. DeFor — 2002
• Unrelated donor marrow transplantation for chronic myelogenous leukaemiaDini, Teresa Lamparelli, Rondelli — 1998
• Increased Infection-Related Mortality in KIR-Ligand–Mismatched Unrelated Allogeneic Hematopoietic Stem-Cell TransplantationMarie Schaffer, Karl‐Johan Malmberg, Olle Ringdén — 2004
• Natural killer cell receptors: new biology and insights into the graft-versus-leukemia effect.Sherif S. Farag, Todd A. Fehniger, Loredana Ruggeri — 2002
• KIR reconstitution is altered by T cells in the graft and correlates with clinical outcomes after unrelated donor transplantation.Sarah Cooley, Valarie McCullar, Rosanna Wangen — 2005
• Relevance of KIR gene polymorphisms in bone marrow transplantation outcome.Katia Gagne, Géraldine Brizard, B. Gueglio — 2002
• Genotypic inhibitory killer immunoglobulin-like receptor ligand incompatibility enhances the long-term antileukemic effect of unmodified allogeneic hematopoietic stem cell transplantation in patients with myeloid leukemias.Dietrich W. Beelen, Hellmut Ottinger, S. Ferenčík — 2005
• The impact of donor KIR and patient HLA-C genotypes on outcome following HLA-identical sibling hematopoietic stem cell transplantation for myeloid leukemia.Mark Cook, Donald Milligan, Chris Fegan — 2004
• The repertoire of HLA–Cw‐specific NK cell receptors CD158 a/b (EB6 and GL183) in individuals with different HLA phenotypesChristoph Frohn, Peter Schlenke, Holger Kirchner — 1997
• T‐cell alloreactivity dominates natural killer cell alloreactivity in minimally T‐cell‐depleted HLA‐non‐identical paediatric bone marrow transplantationEric Lowe, Victoria Turner, Rupert Handgretinger — 2003

Cited by

• GVHD pathophysiology: is acute different from chronic?Guillermo Sena Medina — 2008
• Engineering antigen-specific primary human NK cells against HER-2 positive carcinomasAndrew J. G. Cairns, Samuel A. Garcia Rosas — 2008
• The role of natural killer cells in cancer therapy.H. R. Riggs, R. Cengiz Ertekin, Trevor Mills — 2010
• Natural killer cells and tumor controlJ.J. Obregón Luna — 2010
• Clinical production and therapeutic applications of alloreactive natural killer cells.David H. McKenna, Diane Kadidlo, Sarah Cooley — 2012
• Risk-associations between HLA-DPB1 T cell epitope matching and outcome of unrelated hematopoietic cell transplantation are independent from HLA-DPA1Katharina Fleischhauer, Marcelo Fernández-Viña, T Wang — 2014
• The Impact of HLA and KIR Ligand Mismatching on Unrelated Allogeneic Hematopoietic Stem Cell Transplantation in Korean Adult PatientsDemak Simbolon — 2014
• Greffes allogéniques à partir de donneurs non apparentésNöel Milpied — 2007
• Greffes allogniques partir de donneurs non apparentsNöel Milpied — 2008
• Study of the activation of peripheral blood and cord blood natural killer cellsR. Alnabhan — 2015
• Killer cell Immunoglobulin-like Receptor (KIR) polymorphism in Haematopoietic Stem Cell Transplantation (HSCT) : The effect of KIR gene and genotype polymorphism on clinical outcome after HSCTA. Schellekens — 2008
• Immunotherapy in acute myeloid leukemiaDolores Grosso, Rosemary Hess, Mark A. Weiss — 2015
• Impact of natural killer cell dose and donor killer‐cell immunoglobulin‐like receptor (KIR) genotype on outcome following human leucocyte antigen‐identical haematopoietic stem cell transplantationJohannes Clausen, Dominik Wolf‎, Andreas Petzer — 2007
• Intercellular protein transfer and regulation of inhibitory NK receptor accessibilityKatja Andersson — 2007
• Natural Killer Cells and the Immune Response in Solid Organ TransplantationWilliam van der Touw, Jonathan S. Bromberg — 2010
• The functional role of the activating receptors Tim-3 and CD16 in human natural killer (NK) cell biologyM. Gleason — 2012
• Use of NK cell activity in cure by transplantWing Leung — 2011
• 自然杀伤细胞与癌症——杀伤细胞免疫球蛋白样受体（KIR）的调控Amanda K. Purdy, Kerry S. Campbell — 2010
• Autologous Stem Cell Transplant Recipients Tolerate Haploidentical Related-Donor Natural Killer Cell Enriched InfusionsHans Klingemann, Carrie Grodman, Elliott C. Cutler — 2012
• Inhibitory killer cell immunoglobulin‐like receptor (iKIR) mismatches improve survival after T‐cell‐repleted haploidentical transplantationMariana Bastos‐Oreiro, Javier Anguita, Carolina Martínez‐Laperche — 2016

Related papers

No related papers recorded.